Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients.
about
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectivePosaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis.Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.Tissue penetration of antifungal agents.Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens.Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice.Posaconazole concentrations in human tissues after allogeneic stem cell transplantation.Intrapulmonary distribution and pharmacokinetics of laninamivir, a neuraminidase inhibitor, after a single inhaled administration of its prodrug, laninamivir octanoate, in healthy volunteersReport from the 4th Advances Against Aspergillosis Conference.
P2860
Q27009221-2CF24583-8F63-46AE-B156-9263C2554590Q35076830-E1703BA0-7900-4C50-A370-F72718AD5230Q36018743-3728AAB5-D30C-462F-9F4B-35EEBD8E69F6Q36933524-FE57ABC3-FFC9-4795-8A5F-9DADCB076E46Q37247452-1A0074FE-BAD8-428C-AEAA-F8C256FA1BB5Q37544911-DFCB0A63-D5C3-4319-8CA9-296B2BCE0656Q37713035-D8DD4D15-FAFB-45B0-9CAE-357B68C4CDAAQ37813420-B41F1A33-6F95-49B6-AFCD-225EAD44A1BAQ37942644-ED0D86A5-3C11-4A17-A4AA-2D77D1C90F50Q38681635-5E92EE13-C5E5-44FE-9DCB-7B5E0422D54CQ40166241-DA04275F-5D72-4396-AE18-C0424E26CB65Q41886285-DF30C522-C2B5-4DDB-86C5-DA17EDD21453Q42110576-53F05B19-056C-4FDE-B5C0-A247DF07AE52Q43408668-3FEAA0B9-358B-4353-9881-FD85E6FA755D
P2860
Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@ast
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@en
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@nl
type
label
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@ast
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@en
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@nl
prefLabel
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@ast
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@en
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@nl
P2093
P2860
P356
P1476
Steady-state intrapulmonary ph ...... in lung transplant recipients.
@en
P2093
Catherine DeVoe
Emily Little
Jeffrey A Golden
John E Conte
P2860
P304
P356
10.1128/AAC.01396-09
P407
P577
2010-06-01T00:00:00Z